Related Experiment Video
Updated: Aug 6, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
RNA-based ATTEC: an RNA-guided autophagy-lysosome platform for targeted protein degradation
Yunqiu Zhang1, Wanting Yang1, Yan Xu1
1Bioresource Utilization Center, Chengdu Institute of Biology, Chinese Academy of Science, Chengdu 610213, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China.
Researchers developed a new RNA aptamer-based strategy called autophagosome-tethering compound (ATTEC) to expand targeted protein degradation (TPD) beyond small molecules. This versatile platform enables degradation of various proteins, including transcription factors and oncoproteins.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Targeted protein degradation (TPD) is a rapidly advancing field in drug discovery.
- Current TPD methods using small molecules have limitations in targeting diverse proteins.
- Expanding TPD to a wider range of proteins is crucial for biomedical research.
Purpose of the Study:
- To introduce a novel RNA aptamer-based autophagosome-tethering compound (ATTEC) strategy.
- To overcome the limitations of small-molecule ligands in targeted protein degradation.
- To demonstrate the versatility and programmability of the ATTEC platform for novel drug discovery.
Main Methods:
- Designed a heterobifunctional molecule (GWD) to recruit LC3 to an RNA aptamer scaffold.
- Utilized genetically encoded tandem aptamer RNA scaffolds for target recognition.
- Employed modular replacement of aptamer units to target different proteins.
Main Results:
- Achieved efficient degradation of multiple transcription factors (E2F1, p50, p65) by modular aptamer replacement.
- Demonstrated targeted degradation of RNA-binding protein RBFOX1 and oncoprotein EGFR in HeLa cells.
- Validated the ATTEC platform as a versatile tool for protein degradation.
Conclusions:
- The aptamer-based ATTEC platform offers a modular and programmable approach to targeted protein degradation.
- This strategy significantly expands the scope of targetable proteins for therapeutic and research applications.
- ATTEC holds substantial promise for advancing innovative drug discovery and fundamental biological research.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

